280 related articles for article (PubMed ID: 24349260)
1. Opposing roles of PKA and EPAC in the cAMP-dependent regulation of schwann cell proliferation and differentiation [corrected].
Bacallao K; Monje PV
PLoS One; 2013; 8(12):e82354. PubMed ID: 24349260
[TBL] [Abstract][Full Text] [Related]
2. Requirement of cAMP signaling for Schwann cell differentiation restricts the onset of myelination.
Bacallao K; Monje PV
PLoS One; 2015; 10(2):e0116948. PubMed ID: 25705874
[TBL] [Abstract][Full Text] [Related]
3. Exchange proteins directly activated by cAMP induce the proliferation of rat anterior pituitary GH3 cells via the activation of extracellular signal-regulated kinase.
Sun W; Jiao W; Huang Y; Li R; Zhang Z; Wang J; Lei T
Biochem Biophys Res Commun; 2017 Apr; 485(2):355-359. PubMed ID: 28216156
[TBL] [Abstract][Full Text] [Related]
4. Differential signaling of cyclic AMP: opposing effects of exchange protein directly activated by cyclic AMP and cAMP-dependent protein kinase on protein kinase B activation.
Mei FC; Qiao J; Tsygankova OM; Meinkoth JL; Quilliam LA; Cheng X
J Biol Chem; 2002 Mar; 277(13):11497-504. PubMed ID: 11801596
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase A-mediated gating of neuregulin-dependent ErbB2-ErbB3 activation underlies the synergistic action of cAMP on Schwann cell proliferation.
Monje PV; Athauda G; Wood PM
J Biol Chem; 2008 Dec; 283(49):34087-100. PubMed ID: 18799465
[TBL] [Abstract][Full Text] [Related]
6. The cAMP effectors Epac and protein kinase a (PKA) are involved in the hepatic cystogenesis of an animal model of autosomal recessive polycystic kidney disease (ARPKD).
Banales JM; Masyuk TV; Gradilone SA; Masyuk AI; Medina JF; LaRusso NF
Hepatology; 2009 Jan; 49(1):160-74. PubMed ID: 19065671
[TBL] [Abstract][Full Text] [Related]
7. Lithium Reversibly Inhibits Schwann Cell Proliferation and Differentiation Without Inducing Myelin Loss.
Piñero G; Berg R; Andersen ND; Setton-Avruj P; Monje PV
Mol Neurobiol; 2017 Dec; 54(10):8287-8307. PubMed ID: 27917448
[TBL] [Abstract][Full Text] [Related]
8. Epac, in synergy with cAMP-dependent protein kinase (PKA), is required for cAMP-mediated mitogenesis.
Hochbaum D; Hong K; Barila G; Ribeiro-Neto F; Altschuler DL
J Biol Chem; 2008 Feb; 283(8):4464-8. PubMed ID: 18063584
[TBL] [Abstract][Full Text] [Related]
9. Retroviral inhibition of cAMP-dependent protein kinase inhibits myelination but not Schwann cell mitosis stimulated by interaction with neurons.
Howe DG; McCarthy KD
J Neurosci; 2000 May; 20(10):3513-21. PubMed ID: 10804191
[TBL] [Abstract][Full Text] [Related]
10. Cyclic AMP-dependent protein kinase and Epac mediate cyclic AMP responses in pancreatic acini.
Chaudhuri A; Husain SZ; Kolodecik TR; Grant WM; Gorelick FS
Am J Physiol Gastrointest Liver Physiol; 2007 May; 292(5):G1403-10. PubMed ID: 17234888
[TBL] [Abstract][Full Text] [Related]
11. Cyclic adenosine 3'-5'-monophosphate (cAMP) exerts proliferative and anti-proliferative effects in pituitary cells of different types by activating both cAMP-dependent protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac).
Vitali E; Peverelli E; Giardino E; Locatelli M; Lasio GB; Beck-Peccoz P; Spada A; Lania AG; Mantovani G
Mol Cell Endocrinol; 2014 Mar; 383(1-2):193-202. PubMed ID: 24373949
[TBL] [Abstract][Full Text] [Related]
12. Axon contact-driven Schwann cell dedifferentiation.
Soto J; Monje PV
Glia; 2017 Jun; 65(6):864-882. PubMed ID: 28233923
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Egr1 expression underlies the anti-mitogenic effects of cAMP in vascular smooth muscle cells.
Kimura TE; Duggirala A; Hindmarch CC; Hewer RC; Cui MZ; Newby AC; Bond M
J Mol Cell Cardiol; 2014 Jul; 72(100):9-19. PubMed ID: 24534707
[TBL] [Abstract][Full Text] [Related]
14. Activation of G protein-coupled estrogen receptor 1 induces coronary artery relaxation via Epac/Rap1-mediated inhibition of RhoA/Rho kinase pathway in parallel with PKA.
Yu X; Zhang Q; Zhao Y; Schwarz BJ; Stallone JN; Heaps CL; Han G
PLoS One; 2017; 12(3):e0173085. PubMed ID: 28278256
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk between PKA and Epac regulates the phenotypic maturation and function of human dendritic cells.
Garay J; D'Angelo JA; Park Y; Summa CM; Aiken ML; Morales E; Badizadegan K; Fiebiger E; Dickinson BL
J Immunol; 2010 Sep; 185(6):3227-38. PubMed ID: 20729327
[TBL] [Abstract][Full Text] [Related]
16. Epac activation converts cAMP from a proliferative into a differentiation signal in PC12 cells.
Kiermayer S; Biondi RM; Imig J; Plotz G; Haupenthal J; Zeuzem S; Piiper A
Mol Biol Cell; 2005 Dec; 16(12):5639-48. PubMed ID: 16207818
[TBL] [Abstract][Full Text] [Related]
17. cAMP/PKA antagonizes thrombin-induced inactivation of endothelial myosin light chain phosphatase: role of CPI-17.
Aslam M; Härtel FV; Arshad M; Gündüz D; Abdallah Y; Sauer H; Piper HM; Noll T
Cardiovasc Res; 2010 Jul; 87(2):375-84. PubMed ID: 20202976
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic and Functional Characteristics of Human Schwann Cells as Revealed by Cell-Based Assays and RNA-SEQ.
Monje PV; Sant D; Wang G
Mol Neurobiol; 2018 Aug; 55(8):6637-6660. PubMed ID: 29327207
[TBL] [Abstract][Full Text] [Related]
19. Functional and cardioprotective effects of simultaneous and individual activation of protein kinase A and Epac.
Khaliulin I; Bond M; James AF; Dyar Z; Amini R; Johnson JL; Suleiman MS
Br J Pharmacol; 2017 Mar; 174(6):438-453. PubMed ID: 28071786
[TBL] [Abstract][Full Text] [Related]
20. PKA and Epac activation mediates cAMP-induced vasorelaxation by increasing endothelial NO production.
García-Morales V; Cuíñas A; Elíes J; Campos-Toimil M
Vascul Pharmacol; 2014 Mar; 60(3):95-101. PubMed ID: 24469067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
